Wednesday, July 8, 2026

pharma · Narcolepsy and Idiopathic Hypersomnia · Narcolepsy Type 1 · CNTA

Centessa Pharmaceuticals

Centessa Pharmaceuticals trial registry — 19 ClinicalTrials.gov studies with program phase, status, and indication context.

1 Ashley Road, Cheshire, WA14 2DT, United Kingdom, GB HQ
2021 Founded
142 Employees
Public company Type
CNTA · NYSE Ticker
Company details
Status
Public
HQ
1 Ashley Road, Cheshire, WA14 2DT, United Kingdom, GB
Founded
2021
Employees
142
Programs
15
Drugs
11
Patents
7
Intelligence · Clinical Trials

Centessa Pharmaceuticals clinical trials

Registry index of 19 ClinicalTrials.gov studies linked to Centessa Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.

Centessa Pharmaceuticals trial registry — 19 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Centessa Pharmaceuticals.

  1. LB101-101 — Phase 2

    Clinical update
  2. ORX750-202 — Phase 2

    Clinical update
  3. ORX750-0201 — Phase 2

    Clinical update
  4. ZF874 — Phase 1

    Clinical update
  5. SerpinPC — Phase 2

    Clinical update
  6. ORX489 Tablets — Phase 1

    Clinical update
  7. ORX142 Tablets — Phase 1

    Clinical update
  8. Lixivaptan — Phase 3

    Clinical update

Trial registry

19 studies